Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Schmid Insider Profile
4 Followers
John Schmid, CFO at Auspex Pharma, holds 138.36K shares in Xeris Pharmaceuticals (Ticker: XERS), holds 3.90K shares in AnaptysBio (Ticker: ANAB), holds 58.95K shares in Poseida Therapeutics (Ticker: PSTX). Most recently, John Schmid Bought ― shares of Xeris Pharmaceuticals on Aug 13, 2024 for an estimated value of 10.11K.
Profitable Transactions
6 out of 6 Profitable Transactions
Average Return
+70.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Schmid holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Schmid
John Schmid's Trading History
Auspex Pharma
May 05, 2015
―
Uninformative Sell
―
―
Neos Therapeutics
Mar 19, 2021
―
Uninformative Sell
―
$0.00
AnaptysBio
Jun 18, 2024
Director
Uninformative Buy
92.70K
$56.74K
Xeris Pharmaceuticals
Aug 13, 2024
Director
Informative Buy
10.11K
$482.87K
Poseida Therapeutics
Jun 18, 2024
Director
Uninformative Buy
―
$557.08K
Design Therapeutics
Mar 25, 2024
Director
Informative Buy
99.66K
$360.24K
Trius Therap
Aug 02, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see John Schmid's performance on stock
You May Also Like
John Schmid insider profile FAQ
What is the percentage of profitable transactions made by John Schmid?
The percentage of profitable transactions made by John Schmid is 100%.
What is the average return per transaction made by John Schmid?
The average return per transaction made by John Schmid is 70.70%.
What stocks does John Schmid hold?
John Schmid holds: ASPX, NEOS, ANAB, XERS, PSTX, DSGN, TSRX stocks.
What was John Schmid’s latest transaction?
John Schmid latest transaction was an Informative Buy of $10.11K.
What was John Schmid's most profitable transaction?
John Schmid’s most profitable transaction was an Informative Buy of XERS stock on May 10, 2024. The return on the trade was 108.50%.
What is John Schmid's role in Auspex Pharma?
John Schmid's role in Auspex Pharma is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.